27 Aug 2020 Governance

Leukaemia UK appoints new CEO

The trustees of Leukaemia UK are delighted to announce that they have appointed Fiona Hazell as CEO of Leukaemia UK. Fiona brings a strong track record in not-for-profit leadership, helping lead two mergers to create the UK’s largest breast cancer charity, as well as critical policy and campaigning successes, in her role as Director of Communications, Engagement & Influencing at Breast Cancer Now since 2014.

Chris Corbin OBE, Chairman of Leukaemia UK Trustees and a Director of Corbin & King, said:

“We are thrilled to welcome Fiona as our new CEO. Fiona brings a wealth of experience in the cancer charity sector and has outstanding leadership qualities. We are confident Fiona will lead Leukaemia UK to make an even more significant impact to those affected by leukaemia and other blood cancers. With blood cancer being the 5th most common type of cancer in the UK, it is essential that we continue to deliver on our objective to fund more vital research and care, especially during these unprecedented times. We look forward to having Fiona at the helm of Leukaemia UK to help deliver this mission.”

Fiona Hazell said:

“I’m hugely excited to be joining the Leukaemia UK team as CEO to drive progress for all those affected by leukaemia and other blood cancers – the UK’s third biggest cancer killer. Now more than ever, blood cancer patients and their families across the UK, need new hope for the future and greater support day-to-day and I look forward to collaborating with our incredible supporters and the wider blood cancer community to meet that challenge.”

Fiona begins on 9th September 2020.

Please do not hesitate to contact us on contribute@leukaemiauk.org.uk if you have any questions or queries.

Find out more about our ground-breaking research and care projects.

September is Blood Cancer Awareness Month, find out ways you can get involved.

Related posts

Leukaemia UK bolsters research and advocacy team, in support of ambitious strategy to accelerate progress in the diagnosis, treatment, and care of leukaemia

30 January 2024

Leukaemia UK bolsters research and advocacy team, in support of ambitious strategy to accelerate progress in the diagnosis, treatment, and care of leukaemia

Leukaemia UK is pleased to announce Dr Simon Ridley as the new Director of Research and Advocacy and Dr Georgia Papacleovoulou as the organisation’s first ever Head of Policy and…

Leukaemia UK appoints Ian McCafferty CBE as their new Chair of Trustees to support new strategy to stop leukaemia devastating lives

7 November 2022

Leukaemia UK appoints Ian McCafferty CBE as their new Chair of Trustees to support new strategy to stop leukaemia devastating lives

Ian McCafferty CBE will take up the role in January 2023, from current Chair of Trustees, Chris Corbin OBE, and will lead the charity as it continues to grow. Chris…

Leukaemia UK announced as one of five charities for star-studded event Shall We Dance? with Dame Arlene Phillips and Anton Du Beke

26 October 2021

Leukaemia UK announced as one of five charities for star-studded event Shall We Dance? with Dame Arlene Phillips and Anton Du Beke

Leukaemia UK is delighted to have been announced as one of five charities for whom the proceeds of a new star-studded dance event, Shall We Dance?, will go towards when it takes place next year.

A new clinical trial announced

21 May 2020

A new clinical trial announced

A study into the impact of severe covid-19 infection on patients who receive stem cell transplants for blood cancers and blood disorders.